ReviewFrontiers in pharmacology2021

Improving the Dysregulation of FoxO1 Activity Is a Potential Therapy for Alleviating Diabetic Kidney Disease.

Yan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.